What is the Impact Factor of Expert Opinion on Drug Safety?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Expert Opinion on Drug Safety is 3.00, ranking in quartile Q2 of Web of Science (SCIE).

Is Expert Opinion on Drug Safety indexed in Web of Science or Scopus?

Yes, Expert Opinion on Drug Safety is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.860 (Q2) and an H-index of 101.

Who publishes Expert Opinion on Drug Safety and what is the Article Processing Charge (APC)?

Expert Opinion on Drug Safety is published by Taylor and Francis Ltd.. The estimated Article Processing Charge (APC) is approximately $3,225 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Expert Opinion on Drug Safety?

The official ISO-4 abbreviation of Expert Opinion on Drug Safety is "EXPERT OPIN. DRUG SAF" with common acronym "eods". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #6,194Review JournalHybrid

Expert Opinion on Drug Safety

Acronym:eods

•

Abbreviation (ISO):EXPERT OPIN. DRUG SAF

•

Identifier (ISSN):1474-0338(Print)/1744-764X(Online)

•

Publisher:Taylor and Francis Ltd.

Official Website Submission Portal Compare

Clarivate IF (2026)

3↓ -0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Expert Opinion on Drug Safety

WoS Q2

Annual Impact Factor Metric

Current (2026):3

Scopus SJR & RankScopus Q2

0.86

#6,194

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

101

101 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate3.3%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

160articles/year

2.02% Gold OA•58% Original Research

Aims & Scope

Expert Opinion on Drug Safety ranks #62 of 216 in the Pharmacology & Pharmacy category in the 2008 ISI Journal Citation Reports. Expert Opinion on Drug Safety (ISSN 1474-0338 [print], 1744-764X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of drug safety and original papers on the clinical implications of drug treatment safety issues, providing expert opinion on the scope for future development.

Topics Covered (Recognized by AI)

MedicineBiology93.7%Internal medicine88.5%Pharmacology73.9%Pathology56.9%Psychology54.6%Psychiatry51.3%Intensive care medicine49.3%Genetics48.6%Adverse effect46.6%Chemistry42.6%Surgery36.4%Biochemistry35.6%Endocrinology33.4%Immunology28.1%Drug25.9%Bioinformatics21.8%

Primary Research Areas

Medicine Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank169/356

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank135/356

IndexSCIE

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRSCIE	169/356	Q2
PHARMACOLOGY & PHARMACY	JCISCIE	135/356	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3

Articles / Year45

Total Citations16

2025

IF3.1

Articles / Year212

Total Citations435

2024

IF3

Articles / Year302

Total Citations1,505

2023

IF3.1

Articles / Year176

Total Citations1,659

2022

IF4.011

Articles / Year109

Total Citations1,752

Year	Impact Factor	Articles / Year	Total Citations
2026	3	45	16
2025	3.1	212	435
2024	3	302	1,505
2023	3.1	176	1,659
2022	4.011	109	1,752
2021	4.25	170	2,674
2020	3.383	174	3,701
2019	3.22	124	3,712
2018	3.156	115	3,668
2017	—	140	4,614
2016	—	182	6,493
2015	—	179	5,829

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,194Scopus Q2SCImago Profile

Scopus Coverage:2002-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q2

0.86

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

3.09

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,225 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,668

3-Year Documents476

Citable Documents439

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2

Pharmacology (medical)Q2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 3.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Expert Opinion on Drug Safety (acronym: eods, abbr: EXPERT OPIN. DRUG SAF, ISSN: 1474-0338) is a peer-reviewed international scholarly journal in the field of Medicine, published by Taylor and Francis Ltd. in England since 2002. The periodical holds a Journal Impact Factor (JIF) of 3.00, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.860 (Q2), an H-index of 101.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 160 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,225 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.